{"disease":{"id":"stargardt-s-macular-dystrophy","name":"stargardt s macular dystrophy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03364153","title":"Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":121,"lead_sponsor_name":"Astellas Pharma Global Development, Inc.","has_results":true},{"nct_id":"NCT07425574","title":"A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults","phase":"","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Astellas Pharma Global Development, Inc.","has_results":false},{"nct_id":"NCT06942572","title":"A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":57,"lead_sponsor_name":"Splice Bio","has_results":false},{"nct_id":"NCT05674058","title":"Function and Imaging Assessments for G1961E-associated Stargardt Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":20,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT01345006","title":"Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Astellas Institute for Regenerative Medicine","has_results":false},{"nct_id":"NCT02445612","title":"Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients","phase":"","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Astellas Institute for Regenerative Medicine","has_results":false},{"nct_id":"NCT01469832","title":"Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Astellas Institute for Regenerative Medicine","has_results":false},{"nct_id":"NCT02941991","title":"A Follow up Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)","phase":"","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Astellas Institute for Regenerative Medicine","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}